{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T06:43:09Z","timestamp":1697870589355},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T00:00:00Z","timestamp":1200873600000},"content-version":"vor","delay-in-days":8908,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Autonomic Pharmacology"],"published-print":{"date-parts":[[1983,9]]},"abstract":"<jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>\u03b2\u2010Adrenoreceptor antagonists containing several pharmacophores, so called alprenolol\u2010Jeffamines, were studied. These compounds are derived from Jeffamine<jats:sup>R<\/jats:sup> NH<jats:sub>2<\/jats:sub>\u2010CH\u2010(CH<jats:sub>3<\/jats:sub>)\u2010CH<jats:sub>2<\/jats:sub>\u2010[\u2010O\u2010CH<jats:sub>2<\/jats:sub>\u2010CH(CH<jats:sub>3<\/jats:sub>)\u2010]<jats:sub>n<\/jats:sub>\u2010 NH<jats:sub>29<\/jats:sub>n = 2.6 ave. by substitution of nitrogen with 3\u2010(2\u2010allylphenoxy)\u20102\u2010hydroxypropyl groups, which are part of the Alprenolol<jats:sup>R<\/jats:sup> pharmacophore.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Alprenolol\u2010Jeffamines inhibited (\u2010)isoprenaline stimulated adenylate cyclase activity; the derivative with one pharmacophore was about 4\u2010fold and the derivative with two pharmacophores was about 17\u2010fold less potent than (+)alprenolol; the trisubstituted derivative which has one complete and two partial pharmacophores was ineffective.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The ratio of K<jats:sub>i<\/jats:sub>'s for inhibition of (\u2010)<jats:sup>3<\/jats:sup>H\u2010DHA binding and for inhibition of adenylate cyclase were approximately one for each derivative.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>When (+)alprenolol\u2010Jeffamine derivatives were injected intraperitoneally into rats and heart membranes or homogenates were prepared 18\u201320 h afterwards, the mono, di, and trisubstituted derivatives, but not (+)alprenolol, inhibited bindng of (\u2010)<jats:sup>3<\/jats:sup>H\u2010DHA. This persistency pattern is different from that observed <jats:italic>in vitro<\/jats:italic>, where only di and trisubstituted derivatives are persistent. Slow metabolism\/slow excretion of the monosubstituted derivative may be a source of the increased persistency in vivo.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In similarly prepared animals, the dose\u2010response curve for (\u2010)isoprenaiine stimulated adenylate cyclase was shifted to the right 3\u2010to\u20104 fold for mono and disubstituted derivatives but was unaffected by (+) alprenolol and the trisubstituted derivative.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The results suggest that these derivatives interact with physiologically important \u03b2\u2010adrenoreceptors in vitro, and that, in vivo, they persistently block \u03b2\u2010adrenoreceptors and inhibit isoprenaline stimulated adenylate cyclase.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p>","DOI":"10.1111\/j.1474-8673.1983.tb00535.x","type":"journal-article","created":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T08:43:21Z","timestamp":1200905001000},"page":"195-201","source":"Crossref","is-referenced-by-count":4,"title":["\u03b2\u2010ADRENORECEPTOR ANTAGONISTS WITH MULTIPLE PHARMACOPHORES: PERSISTENT INHIBITION OF RAT HEART ADENYLATE CYCLASE"],"prefix":"10.1111","volume":"3","author":[{"given":"J. W.","family":"KUSIAK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"PITHA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,21]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"585","article-title":"Preclinical and clinical pharmacology of nadolol, a new \u03b2\u2010adrenoreceptor antagonist.","volume":"6","author":"ANTONACCIO M. J.","year":"1980","journal-title":"Drugs Exp. Clin. Res."},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.6.1921"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.3109\/09687688009063885"},{"key":"e_1_2_1_5_1","first-page":"247","article-title":"Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo.","volume":"220","author":"BAKER S. P.","year":"1982","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.44.2.145"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00349a016"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(82)91981-7"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"10312","DOI":"10.1016\/S0021-9258(19)70466-9","article-title":"Regulation of hormone\u2010receptor coupling to adenylyl cyclase.","volume":"255","author":"IYENGAR R.","year":"1980","journal-title":"J. Biol. Chem."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00569402"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(82)90423-3"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(78)90117-0"},{"key":"e_1_2_1_14_1","first-page":"21","article-title":"The pharmacological specificity of beta\u20101 and beta\u20102 adrenergic receptors in rat heart and lung in vitro.","volume":"16","author":"MINNEMAN K. P.","year":"1979","journal-title":"Mol. Pharmac."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00355a002"},{"key":"e_1_2_1_16_1","first-page":"132","volume-title":"Drug Therapy for the Elderly","author":"PROSNITZ E. H.","year":"1982"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(82)90024-7"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(74)90222-X"},{"key":"e_1_2_1_19_1","first-page":"558","article-title":"Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor.","volume":"21","author":"SHIMOHIGASHI Y.","year":"1982","journal-title":"Mol. Pharmac."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.32.4.407"},{"key":"e_1_2_1_21_1","first-page":"363","article-title":"Cyclic AMP and contractile activity in heart.","volume":"8","author":"TSIEN R. W.","year":"1977","journal-title":"Adv. Cyclic Nucleotide Res."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.4.1009"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.50.2.161"}],"container-title":["Journal of Autonomic Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1474-8673.1983.tb00535.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1474-8673.1983.tb00535.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T05:49:07Z","timestamp":1697780947000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1474-8673.1983.tb00535.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1983,9]]}},"alternative-id":["10.1111\/j.1474-8673.1983.tb00535.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1474-8673.1983.tb00535.x","archive":["Portico"],"relation":{},"ISSN":["0144-1795","1365-2680"],"issn-type":[{"value":"0144-1795","type":"print"},{"value":"1365-2680","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,9]]}}}